L-ORNITHINE L- ASPARTATE( LOLA) VERSUS STANDARD MEDICAL THERAPY (SMT) FOR IMPROVEMENT OF SARCOPENIA IN PATIENTS WITH CIRRHOSIS - A RANDOMIZED OPEN LABEL TRIAL

被引：0
|
作者：
Najar, Rameez Raja [1 ]
Sahney, Amrish [1 ]
Wadhavan, Manav [1 ]
Ganesan, Prem Kumar [1 ]
Kumar, Ajay [1 ]
Vij, Jc [1 ]
Berry, Neha [1 ]
Reethesh, S. R. [1 ]
Sondhi, Pulkit [1 ]
Ansari, Md Nuruddin [1 ]
机构：
[1] BLK MAX SS Hosp New Delhi, New Delhi, India
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3055-A
引用
收藏
页码：S1373 / S1373
页数：1
相关论文
共 30 条
  • [1] l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
    Roger F. Butterworth
    Mark J. W. McPhail
    Drugs, 2019, 79 : 31 - 37
  • [2] L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
    Butterworth, Roger F.
    McPhail, Mark J. W.
    DRUGS, 2019, 79 (Suppl 1) : 31 - 37
  • [3] Efficacy and safety of L-ornithine-L-aspartate (LOLA) administration. Open label randomized controlled trial versus lactulose in cirrhotic patients with hyperammonemic hepatic encephalopathy
    Poo, J. L.
    Gongora, J.
    Sanchez-Avila, J. F.
    Aguilar-Castillo, S.
    Garcia Ramos, G.
    Fernandez-Zertuche, M.
    Rodriguez-Fragoso, L.
    Uribe, M.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S36 - S36
  • [4] Secondary prophylaxis of hepatic encephalopathy in cirrhosis: A double blind randomized controlled trial of L-ornithine L-aspartate versus placebo
    Varakanahalli, S.
    Sharma, B.
    Sachdeva, S.
    Dahale, A.
    Srivastava, S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S43 - S43
  • [5] Prospective randomized pilot trial of IV L-ornithine-L-aspartate (LOLA) vs. placebo on postural control in patients with cirrhosis
    Schmid, M.
    Koenig, F.
    Ferenci, P.
    Gangl, A.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S123 - S123
  • [6] Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo
    Varakanahalli, Shivakumar
    Sharma, Barjesh C.
    Srivastava, Siddharth
    Sachdeva, Sanjeev
    Dahale, Amol S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (08) : 951 - 958
  • [7] Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials
    He, Qiufeng
    Mao, Chuangjie
    Chen, Zhili
    Zeng, Yilan
    Deng, Yang
    Hu, Rong
    ARAB JOURNAL OF GASTROENTEROLOGY, 2024, 25 (02) : 84 - 92
  • [8] L-Ornithine L-Aspartate [LOLA] Improves Both Severe Encephalopathy and Survival in Patients With Liver Cirrhosis: Results of RCTs, Systematic Reviews and Meta-Analyses
    Butterworth, Roger F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (9S): : S22 - S22
  • [9] A double-blind, randomized, placebo-controlled trial of intravenous l-ornithine-l-aspartate on postural control in patients with cirrhosis
    Schmid, Monika
    Peck-Radosavljevic, Markus
    Koenig, Franz
    Mittermaier, Christian
    Gangl, Alfred
    Ferenci, Peter
    LIVER INTERNATIONAL, 2010, 30 (04) : 574 - 582
  • [10] CLINICAL TRIAL TO EVALUATE THE EFFICACY OF PRIMARY PROPHYLAXIS WITH L-ORNITHINE L-ASPARTATE TO PREVENT THE DEVELOPMENT OF OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS AND ACUTE VARICEAL BLEEDING
    Higuera-de la Tijera, F.
    Servin-Caamano, A. I.
    Salas-Gordillo, F.
    Abdo-Francis, J. M.
    Camacho-Aguilera, J.
    Perez-Hernandez, J. L.
    Jimenez-Ponce, F.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S260 - S260
123